Regenxbio (RGNX) Change in Acquisitions & Divestments (2016 - 2025)

Regenxbio's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at -$218.2 million for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments rose 6.22% year-over-year to -$218.2 million; the TTM figure through Dec 2025 stood at $62000.0 (down 98.93% YoY), while the FY2025 annual figure was $62000.0, down 98.93% from the prior year.
• Change in Acquisitions & Divestments for Q4 2025 stood at -$218.2 million, down from $82.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $283.5 million in Q4 2023, with the low at -$232.7 million in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $57.7 million (2021), against an average of $33.2 million.
• Peak annual rise in Change in Acquisitions & Divestments reached 542.39% in 2023, while the deepest fall reached 340.61% in 2023.
• Regenxbio's Change in Acquisitions & Divestments stood at $33.7 million in 2021, then surged by 30.96% to $44.1 million in 2022, then surged by 542.39% to $283.5 million in 2023, then tumbled by 182.06% to -$232.7 million in 2024, then increased by 6.22% to -$218.2 million in 2025.
• Business Quant data shows RGNX's Change in Acquisitions & Divestments at -$218.2 million in Q4 2025, $82.2 million in Q3 2025, and $71.1 million in Q2 2025.